STA
Pictures
Slovensko
Friday, Jan 3, 2025
Login
Email
Password
Login
Not registered yet?
Register
Forgot your password?
Login with Facebook
Login with Google
Economy
Society
Culture
Education
Information Technology
Health
Tourism
Leisure
Lifestyle
Science
Sports
Humanitarian Actions
Election
About the service
How to order
Receive notifications
Contact
24.12.2007 08:58
( BW)(PA-MERCK/ISENTRESS)(MRK) ISENTRESS(R) (raltegravir) iz podjetja MSD, prvi integrazni Inhibitor, ki ga je odobrila Komisija Evropske unije
26.11.2007 15:20
Marketing Application for Vorinostat Filed in Europe for the Treatment of Advanced, Refractory Cutaneous T-Cell Lymphoma
16.11.2007 15:06
Izdano pozitivno mnenje za MSD-jev ISENTRESS(R) (raltegravir), prvega v novem razredu t.i. integraznih inhibitorjev za zdravljenje virusa HIV
26.01.2007 09:26
JANUVIA (R) First in New Class of Oral Treatments Known as DPP-4 Inhibitors, Recommended for Approval for the Treatment of Type 2 Diabetes in the European Union
16.11.2006 15:09
MSD-jev preizkusni MK-0524 pomembno znižuje spiranje, ki ga povzroča prekomerno izločanje Niacina v fazi 2
17.08.2006 14:44
Expanded Access Program for MK-0518, an Investigational HIV Integrase Inhibitor, Established for Patients with Limited Available Treatment Options
14.08.2006 08:34
An Investigational Oral HIV Integrase Inhibitor, MK-0518, in Combination Therapy Achieved Comparable HIV RNA Reduction to Efavirenz in Combination Therapy in Treatment-Naive, HIV-Infected Patients at 24 Weeks
13.02.2006 09:11
Merck Sharp & Dohme (MSD) objavlja vmesne rezultate druge faze študije MK-0518, raziskovalni oralni zaviralec integraze HIV
STA Picture Service